1. Home
  2. VRTS vs NBTX Comparison

VRTS vs NBTX Comparison

Compare VRTS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Investment Partners Inc.

VRTS

Virtus Investment Partners Inc.

HOLD

Current Price

$162.57

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$21.88

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTS
NBTX
Founded
1988
2003
Country
United States
France
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
VRTS
NBTX
Price
$162.57
$21.88
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$176.60
$8.00
AVG Volume (30 Days)
87.0K
29.6K
Earning Date
02-06-2026
09-30-2025
Dividend Yield
5.88%
N/A
EPS Growth
18.44
N/A
EPS
19.47
N/A
Revenue
$878,336,000.00
$11,930,711.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$145.24
P/E Ratio
$8.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$142.18
$2.95
52 Week High
$215.06
$30.35

Technical Indicators

Market Signals
Indicator
VRTS
NBTX
Relative Strength Index (RSI) 43.15 45.33
Support Level $165.17 $21.01
Resistance Level $171.15 $22.74
Average True Range (ATR) 4.24 0.77
MACD -0.72 0.05
Stochastic Oscillator 15.61 31.89

Price Performance

Historical Comparison
VRTS
NBTX

About VRTS Virtus Investment Partners Inc.

Virtus Investment Partners Inc provides investment management and related services to institutions and individuals. It uses a multi-manager, multi-style approach, offering investment strategies from investment managers, each having its distinct investment style, autonomous investment process, and individual brand, as well as from select unaffiliated managers for certain funds. Through its multi-manager model, the group provides investment managers with distribution, business, and operational support. The Company operates in one business segment, namely as an asset manager providing investment management and related services for individual and institutional clients.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: